↓ Read PDF
01 · ABSTRACT

Abstract

Intravesical capsaicin has been used as a treatment for detrusor overactivity and bladder pain syndromes due to its desensitizing effect on C-fiber afferents. However, patient responses vary widely in both efficacy and tolerability.  As a therapeutic option, intravesical capsaicin has largely been replaced by botulinum toxin. However, the drug may still be considered in select cases of refractory disease or within the context of research protocols.

↓ Read PDF
02 · PUBLICATION RECORD

Article details

JournalMedical Research Archives
IssueVol 13 No 9 (2025): Vol.13, Issue 9, September 2025
SectionResearch Articles
Published25 September 2025
DOI10.18103/mra.v13i9.6940
ISSN2375-1924
03 · RIGHTS & REUSE

Rights & reuse

This article is published under a Creative Commons Attribution License (CC BY 3.0) and may be shared or distributed by anyone as long as attribution is given to the journal.

Authors & affiliations

KA

Karl-Erik Andersson

Wake Forest Institute for Regenerative Medicine, Winston Salem, Winston Salem, NC, United States ; Department of Laboratory Medicine, Lund University, Lund, Sweden

Medical Research Archives

Submit your own article

Register as an author to reserve your spot in the next issue of the Medical Research Archives.

Start your submission  ↗